{
    "2018-05-08": [
        [
            {
                "time": "",
                "original_text": "[增持评级]安图生物(603658)公司更新报告：微生物质谱注册获批 竞争优势不断提升",
                "features": {
                    "keywords": [
                        "安图生物",
                        "微生物质谱",
                        "注册获批",
                        "竞争优势"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]安图生物(603658)事项点评：质谱获批 微生物产品线升级",
                "features": {
                    "keywords": [
                        "安图生物",
                        "质谱获批",
                        "微生物产品线",
                        "升级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药股表现分化",
                "features": {
                    "keywords": [
                        "医药股",
                        "表现分化"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]安图生物(603658)简评：微生物质谱正式上市 进口替代开辟新战场",
                "features": {
                    "keywords": [
                        "安图生物",
                        "微生物质谱",
                        "正式上市",
                        "进口替代",
                        "新战场"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}